Who Owns ADARx Pharmaceuticals Stock?
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 82.92%
- Institutions (% of float)
- 138.48%
- Held by insiders
- 40.13%
- Institutional holders
- 78
- Institutions 59.9%
- Insiders 40.1%
- Public and other 0.0%
Who owns ADARx Pharmaceuticals stock?
Institutional investors own about 82.9% of ADARx Pharmaceuticals's shares, spread across 78 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 40.13% of ADRX.
The largest institutional holders are Orbimed Advisors LLC. (21.77%), SR One Capital Management, LP (8.94%) and Bain Capital Life Sciences Investors, LLC (6.05%). Together, the top 10 institutions control 53.6% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their ADRX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 24.21M | 21.77% | +100.0% |
| SR One Capital Management, LP | 9.94M | 8.94% | +100.0% |
| Bain Capital Life Sciences Investors, LLC | 6.73M | 6.05% | +100.0% |
| TCG Crossover Management, LLC | 4.12M | 3.70% | +100.0% |
| FMR, LLC | 3.65M | 3.28% | +100.0% |
| Price (T.Rowe) Associates Inc | 2.89M | 2.60% | +100.0% |
| Blackrock Inc. | 2.34M | 2.10% | +100.0% |
| Capital International Investors | 2.13M | 1.92% | +100.0% |
| Siren, L.L.C. | 1.93M | 1.73% | +100.0% |
| Alliancebernstein L.P. | 1.72M | 1.55% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ADRX
| Fund | Shares | % Held |
|---|---|---|
| SmallCap World Fund Inc | 3.25M | 2.92% |
| Fidelity Contrafund | 467.70K | 0.42% |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 430.73K | 0.39% |
| AB DISCOVERY GROWTH FUND, INC. | 427.32K | 0.38% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 400.00K | 0.36% |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 328.20K | 0.30% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 312.50K | 0.28% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 208.00K | 0.19% |
| Fidelity Puritan Trust-Fidelity Balanced Fund | 136.30K | 0.12% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 126.40K | 0.11% |
Frequently asked questions
Who is the largest shareholder of ADARx Pharmaceuticals?
Orbimed Advisors LLC. is the largest institutional shareholder of ADRX, owning 21.77% of shares outstanding (24.21M shares) as of its latest 13F filing.
What percentage of ADARx Pharmaceuticals is owned by institutions?
Institutions own about 82.9% of ADRX shares and 138.5% of the public float.
How much of ADARx Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 40.13% of ADRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.